A Study of Effects of Fesoterodine in Men at High Risk for Overactive Bladder/Detrusor Overactivity Post Robotic-Assisted Lap. Prostatectomy
Clinical trial NCT01661166 · COMPLETED
Trial details
- NCT number
- NCT01661166
- Sponsor
- Abramson Cancer Center at Penn Medicine
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2012-01-01
- Primary completion
- 2013-04-15
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.